Smartphone app for depression alongside TMS or esketamine
Part of Mental health clinical trials.
This study tests a smartphone app called Rejoyn, which is designed to help people with depression who are already taking medication and receiving advanced treatments like TMS or esketamine. The app may help improve your mood and is used alongside your usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a doctor's diagnosis of major depression.
- You must currently be taking an antidepressant medication.
- You must be receiving or starting TMS or esketamine treatment.
- You must have mild or worse depressive symptoms (score of 6 or higher on a depression scale).
- You must have a compatible smartphone and be able to use an app.
- You must be able to provide informed consent and have no other interfering study participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital program (smartphone app or website) to help people with tough-to-treat depression. If you are already receiving advanced treatments like rTMS, ketamine, or ECT at St. Michael's Hospital, you may be able to join and see if this extra digital support improves your mood.
This study tests a smartphone-based emotional monitoring device (EMOCARE) to see if it can accurately measure your mood compared to a standard depression questionnaire. It may help researchers find a simpler way to track depression symptoms.
This study tests a smartphone app (EmoDTx) that monitors mood in people with unipolar depression. It aims to see if the app can provide helpful digital measurements of your mood.
This study tests a new smartphone app designed to help reduce negative symptoms (like lack of motivation or flat emotions) in people with schizophrenia or similar conditions. The app delivers therapy exercises you do on your phone, and researchers want to see if it improves your daily functioning and symptoms.
This study is testing whether a smartphone app can help teens who feel depressed and have lost interest in things. It's looking for youth aged 12–18 with moderate to severe depression who are willing to use the app.
This study tests a smartphone app called Moodivate that helps treat depression through your regular doctor's office using video visits. It's designed for people with mild-to-moderate depression who want a flexible, technology-based treatment option.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.